RENALYTIXAI

WIPO WIPO 2020

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark RENALYTIXAI was filed as Word mark on 12/03/2020 at the World Intellectual Property Organization.

Trademark Details Last update: January 25, 2023

Trademark form Word mark
File reference 1589869
Countries Australia Canada Switzerland China Colombia em United Kingdom Israel India Japan South Korea Mexico Norway New Zealand Russia Singapore
Base trademark US No. 88956754, June 9, 2020
Application date December 3, 2020
Expiration date December 3, 2030

Trademark owner

1460 Broadway
New York NY 10036
US

Trademark representatives

1299 Pennsylvania Ave., NW, Ste. 700 Washington DC 20004 US

goods and services

05 Medical diagnostic blood testing reagents and assays for predicting, identifying and determining the presence and stage of kidney diseases; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing and prediction; test trips, and test strips for predicting, identifying and determining the presence and stage of kidney diseases
10 Blood test collection kit comprised of blood collection bag, holder for medical sample tubes, vials, and medical sample tubes and vials for predicting, identifying and determining the presence and stage of kidney diseases
42 Development of new technology for others in the field of medical devices and medical diagnostic apparatuses; research, development and consultation related thereto in the field of medical devices and medical diagnostic apparatuses through the use of artificial intelligence; laboratory research in the field of kidney diseases; medical research services; research and development services in the field of antibodies; computer software development; providing temporary use of on-line non-downloadable software and software applications using artificial intelligence for medical analysis
44 Medical profile and medical record analysis designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms

Trademark history

Date Document number Area Entry
October 4, 2022 2022/40 Gaz KR RAW: Rule 18ter(2)(ii) GP following a provisional refusal
September 19, 2022 2023/4 Gaz SG RAW: Rule 18ter(2)(ii) GP following a provisional refusal
August 4, 2022 2022/32 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
July 7, 2022 2022/27 Gaz MX Rejection
June 22, 2022 2022/25 Gaz CA Rejection
March 28, 2022 2022/13 Gaz CH Rejection
March 16, 2022 2022/11 Gaz NO Rejection
February 24, 2022 2022/8 Gaz JP Rejection
February 2, 2022 2022/5 Gaz IL Rejection
February 2, 2022 2022/5 Gaz CO Rejection
January 25, 2022 2022/4 Gaz KR Rejection
November 30, 2021 2021/48 Gaz NZ Rejection
September 23, 2021 2021/38 Gaz EM Rejection
September 16, 2021 2021/37 Gaz GB Rejection
September 10, 2021 2021/37 Gaz CN Rejection
July 26, 2021 2021/30 Gaz RU Rejection
July 21, 2021 2021/29 Gaz AU Rejection
July 8, 2021 2021/28 Gaz SG Rejection
May 24, 2021 2021/22 Gaz IN Rejection
December 3, 2020 2021/16 Gaz US Registration

ID: 141589869